← Back to Search

Treatment for Major Depressive Disorder (UNCOVER Trial)

N/A
Waitlist Available
Led By Charles Conway, MD
Research Sponsored by LivaNova
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion; average 2 years
Awards & highlights

Summary

The objective of this study is to collect both active and passive data using a wearable, multi-sensor device (Verily Study Watch) and phone application (Mood App) which aims to capture mental health status, in subjects participating in the RECOVER clinical trial (A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression).

Eligible Conditions
  • Major Depressive Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion; average 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion; average 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of hours of watch wear time
Number of ping sensor recordings
Percentage of PHQ-8 tasks
+1 more

Find a Location

Who is running the clinical trial?

LivaNovaLead Sponsor
64 Previous Clinical Trials
32,345 Total Patients Enrolled
Charles Conway, MDPrincipal InvestigatorWashington University School of Medicine
5 Previous Clinical Trials
7,723 Total Patients Enrolled
~0 spots leftby Oct 2024